Bill Simpson (Past Speaker)

Bill Simpson is Chief Executive Officer of CerRx, Inc., an oncology drug development start-up currently with five compounds.  Two compounds are in phase II trials, one of which is in its pivotal trial for first registration under an orphan designation in the US, EU and Asia. 
Bill has a career filled with leading US and Global Oncology drug development and commercial teams that launched three market leading oncology brands in the US.  Bill has held senior management and executive roles with leading oncology companies including AstraZeneca, Adria Laboratories (now Pfizer), and Ascalon International.